abstract |
The present invention relates to a class of compounds represented by the Formula I n n n or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the α v β 3 and/or α v β 5 integrin. |